Fibrocell Science, Inc., a biotechnology company at the forefront of research into the potential medical and aesthetic use of autologous fibroblasts, announced today that David Pernock, the Company's Chairman and CEO, will be presenting at the 6th Annual OneMedForum San Francisco 2013 to be held January 7th - 9th at The Sir Francis Drake Hotel. Fibrocell's presentation is scheduled for Wednesday, January 9, 2013 at 2:20PM Pacific Time.
The presentation will be webcast live, and a replay will be available at http://onemedplace.com/forum/webcast/.
About Fibrocell Science, Inc.
Fibrocell Science, Inc. (FCSC) is an autologous cellular therapeutic company focused on the development of innovative products for aesthetic, medical and scientific applications. Fibrocell Science, Inc. is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well as its innovative cellular processing technology and manufacturing excellence. For additional information, please visit www.fibrocellscience.com.
Marina Maher Communications LLC
Heather Adamson, 212-485-6806
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.